Global and Japan Terbinafine (Lamisil) Market Insights, Forecast to 2027

Publisher Name :
Date: 20-Dec-2021
No. of pages: 159
Inquire Before Buying

Terbinafine (Lamisil) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Terbinafine (Lamisil) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Terbinafine (Lamisil) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Oral

- External Use

Segment by Application

- Fungal Infection Of The Skin And Mucous Membrane

- Onychomycosis

- Bronchial Asthma

- Gynecological Anti-Infection Preparation

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Perrigo

- Novartis Pharmaceuticals Corporation

- Gokul Pharma

- TEVA

- Mylan Pharmaceuticals

- Pfizer

- Sivem Pharmaceuticals

- Apotex Corporation

- Auro Pharma Inc

- PLIVA

- Jamp Pharma Corporation

- Nu Pharm

- Codal Synto

- Qd Pharmaceuticals

- Pharmel Inc

- Smaart Pharmaceutticals

- Qilu Pharmaceutical

- Qingdao Jinfeng Pharmaceutical

Global and Japan Terbinafine (Lamisil) Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Terbinafine (Lamisil) Product Introduction
1.2 Market by Type
1.2.1 Global Terbinafine (Lamisil) Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 External Use
1.3 Market by Application
1.3.1 Global Terbinafine (Lamisil) Market Size Growth Rate by Application
1.3.2 Fungal Infection Of The Skin And Mucous Membrane
1.3.3 Onychomycosis
1.3.4 Bronchial Asthma
1.3.5 Gynecological Anti-Infection Preparation
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Terbinafine (Lamisil) Market Size, Estimates and Forecasts
2.1.1 Global Terbinafine (Lamisil) Revenue 2016-2027
2.1.2 Global Terbinafine (Lamisil) Sales 2016-2027
2.2 Global Terbinafine (Lamisil), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Terbinafine (Lamisil) Historical Market Size by Region (2016-2021)
2.3.1 Global Terbinafine (Lamisil) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Terbinafine (Lamisil) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Terbinafine (Lamisil) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Terbinafine (Lamisil) Sales Forecast by Region (2022-2027)
2.4.2 Global Terbinafine (Lamisil) Revenue Forecast by Region (2022-2027)
3 Global Terbinafine (Lamisil) Competitor Landscape by Players
3.1 Global Top Terbinafine (Lamisil) Manufacturers by Sales
3.1.1 Global Terbinafine (Lamisil) Sales by Manufacturer (2016-2021)
3.1.2 Global Terbinafine (Lamisil) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Terbinafine (Lamisil) Manufacturers by Revenue
3.2.1 Key Terbinafine (Lamisil) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Terbinafine (Lamisil) Revenue by Manufacturers (2016-2021)
3.2.3 Global Terbinafine (Lamisil) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Terbinafine (Lamisil) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Terbinafine (Lamisil) Revenue in 2020
3.2.6 Global Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Terbinafine (Lamisil) Price by Manufacturers
3.4 Global Terbinafine (Lamisil) Manufacturing Base Distribution, Product Types
3.4.1 Terbinafine (Lamisil) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Terbinafine (Lamisil) Product Type
3.4.3 Date of International Manufacturers Enter into Terbinafine (Lamisil) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Terbinafine (Lamisil) Market Size by Type (2016-2021)
4.1.1 Global Terbinafine (Lamisil) Sales by Type (2016-2021)
4.1.2 Global Terbinafine (Lamisil) Revenue by Type (2016-2021)
4.1.3 Terbinafine (Lamisil) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Terbinafine (Lamisil) Market Size Forecast by Type (2022-2027)
4.2.1 Global Terbinafine (Lamisil) Sales Forecast by Type (2022-2027)
4.2.2 Global Terbinafine (Lamisil) Revenue Forecast by Type (2022-2027)
4.2.3 Terbinafine (Lamisil) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Terbinafine (Lamisil) Market Size by Application (2016-2021)
5.1.1 Global Terbinafine (Lamisil) Sales by Application (2016-2021)
5.1.2 Global Terbinafine (Lamisil) Revenue by Application (2016-2021)
5.1.3 Terbinafine (Lamisil) Price by Application (2016-2021)
5.2 Terbinafine (Lamisil) Market Size Forecast by Application (2022-2027)
5.2.1 Global Terbinafine (Lamisil) Sales Forecast by Application (2022-2027)
5.2.2 Global Terbinafine (Lamisil) Revenue Forecast by Application (2022-2027)
5.2.3 Global Terbinafine (Lamisil) Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Terbinafine (Lamisil) Market Size YoY Growth 2016-2027
6.1.1 Japan Terbinafine (Lamisil) Sales YoY Growth 2016-2027
6.1.2 Japan Terbinafine (Lamisil) Revenue YoY Growth 2016-2027
6.1.3 Japan Terbinafine (Lamisil) Market Share in Global Market 2016-2027
6.2 Japan Terbinafine (Lamisil) Market Size by Players (International and Local Players)
6.2.1 Japan Top Terbinafine (Lamisil) Players by Sales (2016-2021)
6.2.2 Japan Top Terbinafine (Lamisil) Players by Revenue (2016-2021)
6.3 Japan Terbinafine (Lamisil) Historic Market Review by Type (2016-2021)
6.3.1 Japan Terbinafine (Lamisil) Sales Market Share by Type (2016-2021)
6.3.2 Japan Terbinafine (Lamisil) Revenue Market Share by Type (2016-2021)
6.3.3 Japan Terbinafine (Lamisil) Price by Type (2016-2021)
6.4 Japan Terbinafine (Lamisil) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Terbinafine (Lamisil) Sales Forecast by Type (2022-2027)
6.4.2 Japan Terbinafine (Lamisil) Revenue Forecast by Type (2022-2027)
6.4.3 Japan Terbinafine (Lamisil) Price Forecast by Type (2022-2027)
6.5 Japan Terbinafine (Lamisil) Historic Market Review by Application (2016-2021)
6.5.1 Japan Terbinafine (Lamisil) Sales Market Share by Application (2016-2021)
6.5.2 Japan Terbinafine (Lamisil) Revenue Market Share by Application (2016-2021)
6.5.3 Japan Terbinafine (Lamisil) Price by Application (2016-2021)
6.6 Japan Terbinafine (Lamisil) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Terbinafine (Lamisil) Sales Forecast by Application (2022-2027)
6.6.2 Japan Terbinafine (Lamisil) Revenue Forecast by Application (2022-2027)
6.6.3 Japan Terbinafine (Lamisil) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Terbinafine (Lamisil) Market Size YoY Growth 2016-2027
7.2 North America Terbinafine (Lamisil) Market Facts & Figures by Country
7.2.1 North America Terbinafine (Lamisil) Sales by Country (2016-2021)
7.2.2 North America Terbinafine (Lamisil) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Terbinafine (Lamisil) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Terbinafine (Lamisil) Market Facts & Figures by Region
8.2.1 Asia Pacific Terbinafine (Lamisil) Sales by Region (2016-2021)
8.2.2 Asia Pacific Terbinafine (Lamisil) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Terbinafine (Lamisil) Market Size YoY Growth 2016-2027
9.2 Europe Terbinafine (Lamisil) Market Facts & Figures by Country
9.2.1 Europe Terbinafine (Lamisil) Sales by Country (2016-2021)
9.2.2 Europe Terbinafine (Lamisil) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Terbinafine (Lamisil) Market Size YoY Growth 2016-2027
10.2 Latin America Terbinafine (Lamisil) Market Facts & Figures by Country
10.2.1 Latin America Terbinafine (Lamisil) Sales by Country (2016-2021)
10.2.2 Latin America Terbinafine (Lamisil) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Terbinafine (Lamisil) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Terbinafine (Lamisil) Market Facts & Figures by Country
11.2.1 Middle East and Africa Terbinafine (Lamisil) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Perrigo
12.1.1 Perrigo Corporation Information
12.1.2 Perrigo Description and Business Overview
12.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Perrigo Terbinafine (Lamisil) Products Offered
12.1.5 Perrigo Recent Development
12.2 Novartis Pharmaceuticals Corporation
12.2.1 Novartis Pharmaceuticals Corporation Corporation Information
12.2.2 Novartis Pharmaceuticals Corporation Description and Business Overview
12.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Products Offered
12.2.5 Novartis Pharmaceuticals Corporation Recent Development
12.3 Gokul Pharma
12.3.1 Gokul Pharma Corporation Information
12.3.2 Gokul Pharma Description and Business Overview
12.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Gokul Pharma Terbinafine (Lamisil) Products Offered
12.3.5 Gokul Pharma Recent Development
12.4 TEVA
12.4.1 TEVA Corporation Information
12.4.2 TEVA Description and Business Overview
12.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 TEVA Terbinafine (Lamisil) Products Offered
12.4.5 TEVA Recent Development
12.5 Mylan Pharmaceuticals
12.5.1 Mylan Pharmaceuticals Corporation Information
12.5.2 Mylan Pharmaceuticals Description and Business Overview
12.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Products Offered
12.5.5 Mylan Pharmaceuticals Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Terbinafine (Lamisil) Products Offered
12.6.5 Pfizer Recent Development
12.7 Sivem Pharmaceuticals
12.7.1 Sivem Pharmaceuticals Corporation Information
12.7.2 Sivem Pharmaceuticals Description and Business Overview
12.7.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Products Offered
12.7.5 Sivem Pharmaceuticals Recent Development
12.8 Apotex Corporation
12.8.1 Apotex Corporation Corporation Information
12.8.2 Apotex Corporation Description and Business Overview
12.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Apotex Corporation Terbinafine (Lamisil) Products Offered
12.8.5 Apotex Corporation Recent Development
12.9 Auro Pharma Inc
12.9.1 Auro Pharma Inc Corporation Information
12.9.2 Auro Pharma Inc Description and Business Overview
12.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Auro Pharma Inc Terbinafine (Lamisil) Products Offered
12.9.5 Auro Pharma Inc Recent Development
12.10 PLIVA
12.10.1 PLIVA Corporation Information
12.10.2 PLIVA Description and Business Overview
12.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 PLIVA Terbinafine (Lamisil) Products Offered
12.10.5 PLIVA Recent Development
12.11 Perrigo
12.11.1 Perrigo Corporation Information
12.11.2 Perrigo Description and Business Overview
12.11.3 Perrigo Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Perrigo Terbinafine (Lamisil) Products Offered
12.11.5 Perrigo Recent Development
12.12 Nu Pharm
12.12.1 Nu Pharm Corporation Information
12.12.2 Nu Pharm Description and Business Overview
12.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Nu Pharm Products Offered
12.12.5 Nu Pharm Recent Development
12.13 Codal Synto
12.13.1 Codal Synto Corporation Information
12.13.2 Codal Synto Description and Business Overview
12.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Codal Synto Products Offered
12.13.5 Codal Synto Recent Development
12.14 Qd Pharmaceuticals
12.14.1 Qd Pharmaceuticals Corporation Information
12.14.2 Qd Pharmaceuticals Description and Business Overview
12.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Qd Pharmaceuticals Products Offered
12.14.5 Qd Pharmaceuticals Recent Development
12.15 Pharmel Inc
12.15.1 Pharmel Inc Corporation Information
12.15.2 Pharmel Inc Description and Business Overview
12.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Pharmel Inc Products Offered
12.15.5 Pharmel Inc Recent Development
12.16 Smaart Pharmaceutticals
12.16.1 Smaart Pharmaceutticals Corporation Information
12.16.2 Smaart Pharmaceutticals Description and Business Overview
12.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Smaart Pharmaceutticals Products Offered
12.16.5 Smaart Pharmaceutticals Recent Development
12.17 Qilu Pharmaceutical
12.17.1 Qilu Pharmaceutical Corporation Information
12.17.2 Qilu Pharmaceutical Description and Business Overview
12.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Qilu Pharmaceutical Products Offered
12.17.5 Qilu Pharmaceutical Recent Development
12.18 Qingdao Jinfeng Pharmaceutical
12.18.1 Qingdao Jinfeng Pharmaceutical Corporation Information
12.18.2 Qingdao Jinfeng Pharmaceutical Description and Business Overview
12.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Qingdao Jinfeng Pharmaceutical Products Offered
12.18.5 Qingdao Jinfeng Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Terbinafine (Lamisil) Industry Trends
13.2 Terbinafine (Lamisil) Market Drivers
13.3 Terbinafine (Lamisil) Market Challenges
13.4 Terbinafine (Lamisil) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Terbinafine (Lamisil) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Terbinafine (Lamisil) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of External Use
Table 4. Global Terbinafine (Lamisil) Market Size Growth Rate by Application (2021-2027) & (KG)
Table 5. Global Terbinafine (Lamisil) Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Terbinafine (Lamisil) Sales by Regions (2016-2021) & (KG)
Table 7. Global Terbinafine (Lamisil) Sales Market Share by Regions (2016-2021)
Table 8. Global Terbinafine (Lamisil) Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Terbinafine (Lamisil) Sales Forecast by Region (2022-2027) & (KG)
Table 10. Global Terbinafine (Lamisil) Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Terbinafine (Lamisil) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Terbinafine (Lamisil) Sales by Manufacturers (2016-2021) (KG)
Table 14. Global Terbinafine (Lamisil) Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Terbinafine (Lamisil) Manufacturers by Revenue (US$ Million) in 2020
Table 16. Terbinafine (Lamisil) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Terbinafine (Lamisil) Revenue Share by Manufacturers (2016-2021)
Table 18. Global Terbinafine (Lamisil) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Terbinafine (Lamisil) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Terbinafine (Lamisil) as of 2020)
Table 20. Key Manufacturers Terbinafine (Lamisil) Price (2016-2021) (US$/G)
Table 21. Terbinafine (Lamisil) Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Terbinafine (Lamisil) Product Type
Table 23. Date of International Manufacturers Enter into Terbinafine (Lamisil) Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Terbinafine (Lamisil) Sales by Type (2016-2021) (KG)
Table 26. Global Terbinafine (Lamisil) Sales Share by Type (2016-2021)
Table 27. Global Terbinafine (Lamisil) Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Terbinafine (Lamisil) Revenue Share by Type (2016-2021)
Table 29. Terbinafine (Lamisil) Average Selling Price (ASP) by Type (2016-2021) & (US$/G)
Table 30. Global Terbinafine (Lamisil) Sales Forecast by Type (2022-2027) & (KG)
Table 31. Global Terbinafine (Lamisil) Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Terbinafine (Lamisil) Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Terbinafine (Lamisil) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G)
Table 35. Global Terbinafine (Lamisil) Sales by Application (2016-2021) (KG)
Table 36. Global Terbinafine (Lamisil) Sales Share by Application (2016-2021)
Table 37. Global Terbinafine (Lamisil) Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Terbinafine (Lamisil) Revenue Share by Application (2016-2021)
Table 39. Terbinafine (Lamisil) Average Selling Price (ASP) by Application (2016-2021) & (US$/G)
Table 40. Global Terbinafine (Lamisil) Sales Forecast by Application (2022-2027) & (KG)
Table 41. Global Terbinafine (Lamisil) Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Terbinafine (Lamisil) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Terbinafine (Lamisil) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G)
Table 45. Japan Terbinafine (Lamisil) Sales (KG) of Key Companies (2016-2021)
Table 46. Japan Terbinafine (Lamisil) Sales Share by Company (2016-2021)
Table 47. Japan Terbinafine (Lamisil) Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Terbinafine (Lamisil) Revenue Share by Company (2016-2021)
Table 49. Japan Terbinafine (Lamisil) Sales (KG) by Type (2016-2021)
Table 50. Japan Terbinafine (Lamisil) Sales Share by Type (2016-2021)
Table 51. Japan Terbinafine (Lamisil) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Terbinafine (Lamisil) Price (US$/G) by Type (2016-2021)
Table 53. Japan Terbinafine (Lamisil) Sales (KG) by Type (2022-2027)
Table 54. Japan Terbinafine (Lamisil) Sales Share by Type (2022-2027)
Table 55. Japan Terbinafine (Lamisil) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Terbinafine (Lamisil) Revenue Share by Type (2022-2027)
Table 57. Japan Terbinafine (Lamisil) Price (US$/G) by Type (2022-2027)
Table 58. Japan Terbinafine (Lamisil) Sales (KG) by Application (2016-2021)
Table 59. Japan Terbinafine (Lamisil) Sales Share by Application (2016-2021)
Table 60. Japan Terbinafine (Lamisil) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Terbinafine (Lamisil) Price (US$/G) by Application (2016-2021)
Table 62. Japan Terbinafine (Lamisil) Sales (KG) by Application (2022-2027)
Table 63. Japan Terbinafine (Lamisil) Sales Share by Application (2022-2027)
Table 64. Japan Terbinafine (Lamisil) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Terbinafine (Lamisil) Revenue Share by Application (2022-2027)
Table 66. Japan Terbinafine (Lamisil) Price (US$/G) by Application (2022-2027)
Table 67. North America Terbinafine (Lamisil) Sales by Country (2016-2021) & (KG)
Table 68. North America Terbinafine (Lamisil) Sales Market Share by Country (2016-2021)
Table 69. North America Terbinafine (Lamisil) Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Terbinafine (Lamisil) Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Terbinafine (Lamisil) Sales by Region (2016-2021) & (KG)
Table 72. Asia Pacific Terbinafine (Lamisil) Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Terbinafine (Lamisil) Revenue Market Share by Region (2016-2021)
Table 75. Europe Terbinafine (Lamisil) Sales by Country (2016-2021) & (KG)
Table 76. Europe Terbinafine (Lamisil) Sales Market Share by Country (2016-2021)
Table 77. Europe Terbinafine (Lamisil) Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2016-2021)
Table 79. Latin America Terbinafine (Lamisil) Sales by Country (2016-2021) & (KG)
Table 80. Latin America Terbinafine (Lamisil) Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Terbinafine (Lamisil) Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Terbinafine (Lamisil) Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Terbinafine (Lamisil) Sales by Country (2016-2021) & (KG)
Table 84. Middle East and Africa Terbinafine (Lamisil) Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Terbinafine (Lamisil) Revenue Market Share by Country (2016-2021)
Table 87. Perrigo Corporation Information
Table 88. Perrigo Description and Business Overview
Table 89. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 90. Perrigo Terbinafine (Lamisil) Product
Table 91. Perrigo Recent Development
Table 92. Novartis Pharmaceuticals Corporation Corporation Information
Table 93. Novartis Pharmaceuticals Corporation Description and Business Overview
Table 94. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 95. Novartis Pharmaceuticals Corporation Product
Table 96. Novartis Pharmaceuticals Corporation Recent Development
Table 97. Gokul Pharma Corporation Information
Table 98. Gokul Pharma Description and Business Overview
Table 99. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 100. Gokul Pharma Product
Table 101. Gokul Pharma Recent Development
Table 102. TEVA Corporation Information
Table 103. TEVA Description and Business Overview
Table 104. TEVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 105. TEVA Product
Table 106. TEVA Recent Development
Table 107. Mylan Pharmaceuticals Corporation Information
Table 108. Mylan Pharmaceuticals Description and Business Overview
Table 109. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 110. Mylan Pharmaceuticals Product
Table 111. Mylan Pharmaceuticals Recent Development
Table 112. Pfizer Corporation Information
Table 113. Pfizer Description and Business Overview
Table 114. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 115. Pfizer Product
Table 116. Pfizer Recent Development
Table 117. Sivem Pharmaceuticals Corporation Information
Table 118. Sivem Pharmaceuticals Description and Business Overview
Table 119. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 120. Sivem Pharmaceuticals Product
Table 121. Sivem Pharmaceuticals Recent Development
Table 122. Apotex Corporation Corporation Information
Table 123. Apotex Corporation Description and Business Overview
Table 124. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 125. Apotex Corporation Product
Table 126. Apotex Corporation Recent Development
Table 127. Auro Pharma Inc Corporation Information
Table 128. Auro Pharma Inc Description and Business Overview
Table 129. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 130. Auro Pharma Inc Product
Table 131. Auro Pharma Inc Recent Development
Table 132. PLIVA Corporation Information
Table 133. PLIVA Description and Business Overview
Table 134. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 135. PLIVA Product
Table 136. PLIVA Recent Development
Table 137. Jamp Pharma Corporation Corporation Information
Table 138. Jamp Pharma Corporation Description and Business Overview
Table 139. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 140. Jamp Pharma Corporation Product
Table 141. Jamp Pharma Corporation Recent Development
Table 142. Nu Pharm Corporation Information
Table 143. Nu Pharm Description and Business Overview
Table 144. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 145. Nu Pharm Product
Table 146. Nu Pharm Recent Development
Table 147. Codal Synto Corporation Information
Table 148. Codal Synto Description and Business Overview
Table 149. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 150. Codal Synto Product
Table 151. Codal Synto Recent Development
Table 152. Qd Pharmaceuticals Corporation Information
Table 153. Qd Pharmaceuticals Description and Business Overview
Table 154. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 155. Qd Pharmaceuticals Product
Table 156. Qd Pharmaceuticals Recent Development
Table 157. Pharmel Inc Corporation Information
Table 158. Pharmel Inc Description and Business Overview
Table 159. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 160. Pharmel Inc Product
Table 161. Pharmel Inc Recent Development
Table 162. Smaart Pharmaceutticals Corporation Information
Table 163. Smaart Pharmaceutticals Description and Business Overview
Table 164. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 165. Smaart Pharmaceutticals Product
Table 166. Smaart Pharmaceutticals Recent Development
Table 167. Qilu Pharmaceutical Corporation Information
Table 168. Qilu Pharmaceutical Description and Business Overview
Table 169. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 170. Qilu Pharmaceutical Product
Table 171. Qilu Pharmaceutical Recent Development
Table 172. Qingdao Jinfeng Pharmaceutical Corporation Information
Table 173. Qingdao Jinfeng Pharmaceutical Description and Business Overview
Table 174. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 175. Qingdao Jinfeng Pharmaceutical Product
Table 176. Qingdao Jinfeng Pharmaceutical Recent Development
Table 177. Terbinafine (Lamisil) Market Trends
Table 178. Terbinafine (Lamisil) Market Drivers
Table 179. Terbinafine (Lamisil) Market Challenges
Table 180. Terbinafine (Lamisil) Market Restraints
Table 181. Terbinafine (Lamisil) Customers List
Table 182. Terbinafine (Lamisil) Distributors List
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Terbinafine (Lamisil) Product Picture
Figure 2. Global Terbinafine (Lamisil) Sales Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. External Use Product Picture
Figure 5. Global Terbinafine (Lamisil) Sales Market Share by Application in 2020 & 2027
Figure 6. Fungal Infection Of The Skin And Mucous Membrane
Figure 7. Onychomycosis
Figure 8. Bronchial Asthma
Figure 9. Gynecological Anti-Infection Preparation
Figure 10. Other
Figure 11. Terbinafine (Lamisil) Report Years Considered
Figure 12. Global Terbinafine (Lamisil) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Terbinafine (Lamisil) Market Size 2016-2027 (US$ Million)
Figure 14. Global Terbinafine (Lamisil) Sales 2016-2027 (KG)
Figure 15. Global Terbinafine (Lamisil) Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Terbinafine (Lamisil) Sales Market Share by Region (2016-2021)
Figure 17. Global Terbinafine (Lamisil) Sales Market Share by Region in 2020
Figure 18. Global Terbinafine (Lamisil) Revenue Market Share by Region (2016-2021)
Figure 19. Global Terbinafine (Lamisil) Revenue Market Share by Region in 2020
Figure 20. Global Terbinafine (Lamisil) Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Terbinafine (Lamisil) Revenue in 2020
Figure 22. Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Terbinafine (Lamisil) Sales Market Share by Type (2016-2021)
Figure 24. Global Terbinafine (Lamisil) Sales Market Share by Type in 2020
Figure 25. Global Terbinafine (Lamisil) Revenue Market Share by Type (2016-2021)
Figure 26. Global Terbinafine (Lamisil) Revenue Market Share by Type in 2020
Figure 27. Global Terbinafine (Lamisil) Sales Market Share by Application (2016-2021)
Figure 28. Global Terbinafine (Lamisil) Sales Market Share by Application in 2020
Figure 29. Global Terbinafine (Lamisil) Revenue Market Share by Application (2016-2021)
Figure 30. Global Terbinafine (Lamisil) Revenue Market Share by Application in 2020
Figure 31. Japan Terbinafine (Lamisil) Sales Growth Rate 2016-2027 (KG)
Figure 32. Japan Terbinafine (Lamisil) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Japan Terbinafine (Lamisil) Market Share in Global Market 2016-2027
Figure 34. Japan 5 and 10 Largest Terbinafine (Lamisil) Players Market Share by Revenue in Terbinafine (Lamisil) in 2020
Figure 35. Japan Terbinafin
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs